Showing results (151-160 of 219) with videos related to
Sort By:
Pageof 22
The Breast Journal|January 25, 2006
Breast cancer in limited-resource countries: treatment and allocation of resourcesAlexandru Eniu, Robert W Carlson, Zeba Aziz, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Advancing More Equitable Care Through the Development of a Health Equity Report CardAlyssa A Schatz, Shonta Chambers, Gretchen C Wartman, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Policy Challenges and Opportunities to Address Changing Paradigms in Cancer Care DeliveryKaty Winckworth-Prejsnar, James McCanney, Alyssa A Schatz, et al.Cancer|March 7, 2012
Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapyAlice Y Ho, Gaorav Gupta, Tari A King, et al.Breast Cancer Research and Treatment|March 28, 2023
Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survivalPriyanka Narayan, Caroline E Kostrzewa, Zhigang Zhang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Current Practices for Screening and Management of Financial Distress at NCCN Member InstitutionsNandita Khera, Jessica Sugalski, Diana Krause, et al.Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 19, 2013
Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapyAlice Y Ho, Nisha Patel, Nisha Ohri, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelinesRobert W Carlson, D Craig Allred, Benjamin O Anderson, et al.The Breast Journal|May 20, 2003
A roundtable discussion of aromatase inhibitors as therapy for breast cancerD Craig Allred, Michael Baum, Aman U Buzdar, et al.Clinical Breast Cancer|July 9, 2005
Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancerRuth M O'Regan, Jamie H Von Roenn, Robert W Carlson, et al.Pageof 22